… proteasome inhibitor, Bortezomib, all resistant subpopulations were re-sensitized to TRAIL.
While the cells continued to survive under Bortezomib … ), suggesting differential routes of …

… the ubiquitin-proteasome system with proteasome inhibitors, including … Therapeutic proteasome
inhibitors bortezomib, carfilzomib … Differential expressed loci were defined using HOMER …

… -generation reversible proteasome inhibitors with a similar efficacy to bortezomib, and has
… ; (C) TCGA database analysis of the relatively differential expression level (log2) of PLK1 in …

… previously demonstrated experiment with bortezomib [52], … Differential gene expressions
were performed based on p-… in response to proteasomal inhibition in breast cancer cell lines [37]…

… breast cancer cell lines, SUM149 and MDA-MB-231 (Figure 1e). Proteasome activity in these
cells … were treated for 1 hr at indicated concentrations of bortezomib (Btz) and carfilzomib (…

… cellular ATP levels to ensure survival in differentiated plasma … the transcriptional program of
human breast tumors. Proc Natl … to the proteasome inhibitor bortezomib is correlated with the …

… Furthermore, our data point out the differential effect of … induced by proteasome inhibitors
bortezomib and carfilzomib. This … between proteasome inhibitors and AMG9810 in MM cells. …

… , the proteasome inhibitor (PI) bortezomib (BRZ) represented a major breakthrough in MM
treatment in … Differential expression of probes between the sensitive and resistant HMCLs was …

… PCM cells are particularly vulnerable to the ER stress inducing agents, such as proteasome
inhibitors (PIs, bortezomib… This has been confirmed by reports showing that, in breast cancer …

… In in vivo studies on mice bearing human breast cancer cells (MDA-MB-… differentiated
between cancer and healthy cells. At the molecular level, BMV109 was found in mononuclear cells, …